News on immunohistochemistry and other tissue-based testing methods.
In a recent study the researchers used the approach to measure levels of eight proteins in a breast cancer tissue section using a total of 180 antibody spots.
Total revenues reached $2.54 billion during the quarter, while LabCorp Diagnostics' revenues rose more than 8 percent to $1.80 billion.
OncoDNA said that it will use next-generation sequencing and immunohistochemistry assays to analyze patient to identify potential biomarkers and molecular alterations.
Collaborators have created an atlas that compares available PD-L1 IHC assays and reveals areas of debate, including challenges encountered by clinicians.
Castle will use the proceeds to accelerate marketing and new product development related to its molecular prognostic tests for patients with underserved cancers.
